Oxycodone vs. Tapentadol
Links shared publicly online about this topic
Fewer Elderly Patients with Moderate-to-Severe Chronic Pain Discontinue Tapentadol Extended-Release vs Oxycodone Controlled-Release Due to Adverse Events - MPR
empr.com — “Tapentadol extended-release (ER), an investigational drug, was associated with better gastrointestinal tolerability in elderly patients with moderate-to-severe chronic pain, with fewer discontinuing the study due to treatment-emergent adverse events (TEAEs) than oxycodone controlled-release (CR), investigators concluded in a presentation during the 29th Annual Scientific Meeting of the American Pain Society.” View full resource at empr.com
Most Recently Shared on May 8, 2010 at 2:42 pm By:
APS: Fewer Elderly Patients with Moderate-to-Severe Chronic Pain Discontinue Tapentadol Extended-Release vs Oxycod... http://bit.ly/9yMFpG
Fewer Elderly Patients with Moderate-to-Severe Chronic Pain Discontinue Tapentadol Extended-Release vs Oxycodone Controlled-Release Due to Adverse Events - ONA
oncologynurseadvisor.com — “Tapentadol extended-release (ER), an investigational drug, was associated with better gastrointestinal tolerability in elderly patients with moderate-to-severe chronic pain, with fewer discontinuing the study due to treatment-emergent adverse events (TEAEs) than oxycodone controlled-release (CR), investigators concluded in a presentation during the 29th Annual Scientific Meeting of the American Pain Society.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 8, 2010 at 1:48 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Fewer Elderly Patients with Moderate-to-Severe Chronic Pain Discontinue Tapentadol Extended… http://goo.gl/fb/DK60M
Rheumatology Medical News about Osteoarthritis, Knee Pain; Tapentadol Extended Release; Oxycodone Controlled Release
mdlinx.com — “Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee: A Randomized, Double-Blind, Placebo- and Active-Controlled Phase III Study” View full resource at mdlinx.com
Most Recently Shared on July 5, 2010 at 2:06 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the... http://bit.ly/aEKwui #Rheumatology
Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients With Chronic Low Back Pain - Drugs.com MedNews
drugs.com — “Phase 3 safety and efficacy data comparing tapentadol extended release (ER) tablets, an investigational pain medication, to placebo in patients with moderate to” View full resource at drugs.com
Most Recently Shared on September 27, 2010 at 2:10 pm By:
Drugs and Devices OW OW Health
Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients With Chronic Low Back Pain:... http://bit.ly/cqnARq #drug
Tapentadol ER Demonstrates Better GI Tolerability When Compared with Oxycodone CR - ONA
oncologynurseadvisor.com — “Results of a post-hoc analysis presented at the American Pain Society’s 30th Annual Scientific Meeting demonstrated that tapentadol extended-release is associated with comparable analgesia and better gastrointestinal tolerability than oxycodone HCl controlled-release.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 20, 2011 at 5:57 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Tapentadol ER Demonstrates Better GI Tolerability When Compared with Oxycodone CR http://goo.gl/fb/zmaRJ
Tapentadol ER Demonstrates Better GI Tolerability When Compared with Oxycodone CR - MPR
empr.com — “Results of a post-hoc analysis presented at the American Pain Society’s 30th Annual Scientific Meeting demonstrated that tapentadol extended-release is associated with comparable analgesia and better gastrointestinal tolerability than oxycodone HCl controlled-release.” View full resource at empr.com
Most Recently Shared on May 20, 2011 at 6:20 pm By:
MPR News: Tapentadol ER Demonstrates Better GI Tolerability When Compared with Oxycodone CR: Results of a post-h... http://bit.ly/mgzB9z
Data Comparing NUCYNTA (Tapentadol) Tablets to Oxycodone Immediate Release Tablets Presented At 2010 American Pain Society Annual Meeting
jnj.com — “Johnson & Johnson news and information regarding our operations, products, leaders, and our charitable giving.” View full resource at jnj.com
Most Recently Shared on May 7, 2010 at 9:29 pm By:
Data Comparing NUCYNTA® (Tapentadol) Tablets to Oxycodone Immediate Release Tablets Presented At 2010 American Pa... http://bit.ly/9kiXa8
Data Comparing NUCYNTA(R) (Tapentadol) Tablets To Oxycodone Immediate Release Tablets Presented At 2010 American Pain Society Annual Meeting
medicalnewstoday.com — “A post-hoc analysis of a Phase 3 safety study demonstrated that NUCYNTA® (tapentadol) tablets were associated with a lower incidence of nausea, vomiting and constipation when compared to oxyco” View full resource at medicalnewstoday.com
Most Recently Shared on May 10, 2010 at 1:39 pm By:
MNT Pain News Pain Management and Health News
Data Comparing NUCYNTA(R) (Tapentadol) Tablets To Oxycodone Immediate Release Tablets Presented At 2010 American Pain ... http://mnt.to/3CpX
Elderly Patients with Moderate-to-Severe Low Back or Osteoarthritis Pain Tolerate Tapentadol Immediate Release (IR) Better than Oxycodone IR - ONA
oncologynurseadvisor.com — “Lower incidences and rates of discontinuation due to gastrointestinal treatment-emergent adverse events (TEAEs) among elderly patients with moderate-to-severe low back or osteoarthritis pain suggest that tapentadol immediate-release (IR) may be a better treatment option than oxycodone IR, according to a study presented during the 29th Annual Scientific Meeting of the American Pain Society.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 7, 2010 at 4:09 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Elderly Patients with Moderate-to-Severe Low Back or Osteoarthritis Pain Tolerate Tapentadol… http://goo.gl/fb/H7VXv
Elderly Patients with Moderate-to-Severe Low Back or Osteoarthritis Pain Tolerate Tapentadol Immediate Release (IR) Better than Oxycodone IR - MPR
empr.com — “Lower incidences and rates of discontinuation due to gastrointestinal treatment-emergent adverse events (TEAEs) among elderly patients with moderate-to-severe low back or osteoarthritis pain suggest that tapentadol immediate-release (IR) may be a better treatment option than oxycodone IR, according to a study presented during the 29th Annual Scientific Meeting of the American Pain Society.” View full resource at empr.com
Most Recently Shared on May 7, 2010 at 5:00 pm By:
APS: Elderly Patients with Moderate-to-Severe Low Back or Osteoarthritis Pain Tolerate Tapentadol Immediate Releas... http://bit.ly/aluOZI
Tapentadol Extended Release Associated with Lower Rates, Longer Times to Discontinuation Due to Gastrointestinal Adverse Events than Oxycodone Controlled-Release - MPR
empr.com — “Prior opioid experience had no effect on discontinuation of tapentadol extended-release (ER) due to gastrointestinal treatment-emergent adverse events (TEAEs) in patients with moderate-to-severe chronic low back or osteoarthritis pain, investigators reported during the American Pain Society's 29th Annual Scientific Meeting.” View full resource at empr.com
Most Recently Shared on May 6, 2010 at 9:34 pm By:
APS: Tapentadol Extended Release Associated with Lower Rates, Longer Times to Discontinuation Due to Gastrointesti... http://bit.ly/a08qSw
Watson Brand Oxycodone Vs. Mallinkrodt Brand Oxycodone (Newest posts first) - The People's Medicine Community
prescriptiondrug-info.com — “I have 3 herniated disc in my lower back and severe nerve damage down my leg I ve been on Oxycodone 10 325 for the past 4 years I have always gotten the Watson brand which would keep my pain under control somewhat up until the other day I was given Mallinkrodt brand because my pharmacy had ran out o (Newest posts first)” View full resource at prescriptiondrug-info.com
Most Recently Shared on May 1, 2011 at 11:35 pm By:
" I have 3 herniated disc in my lower back and severe nerve damage down my leg. I've been on Oxycodone 10/325 http://PD0.US/F217107
(2) 15mg Oxycodone'S Vs. (1) 30mg Oxycodone (Newest posts first) - The People's Medicine Community
prescriptiondrug-info.com — “My doctor prescribed me 60 30mg Oxycodone s But my pharmacist gave me 120 15 mg pills as a substitute My question is will 2 15 mg pills have the same effect as 1 30 mg pill to have a real comparison you must break the 15 s in half when you swallow them to breaking 1 30mg in half (Newest posts first)” View full resource at prescriptiondrug-info.com
Most Recently Shared on February 8, 2011 at 3:05 am By:
" to have a real comparison, you must break the 15's in half when you swallow them to breaking 1-30mg in half. http://PD0.US/F192905
Endocet Vs Oxycodone (Newest posts first) - The People's Medicine Community
prescriptiondrug-info.com — “I HAVE BEEN ON OXYCODONE FOR OVER 2 YEARS AND MY DRUG STORE RAN OUT AND GAVE ME ENDOCET SAID IT WAS THE SAME THING BUT MY BODY TELLS ME THAT IT S NOT THE SAME HAS ANYONE ELSE HAD ANY PROBLEMS WITH THIS CHANGE I dont care about the science I KNOW MY BODY Speaking from experience ENDOCET IS WORTHLESS (Newest posts first)” View full resource at prescriptiondrug-info.com
Most Recently Shared on February 25, 2011 at 6:05 am By:
" I dont care about the science, I KNOW MY BODY. Speaking from experience, ENDOCET IS WORTHLESS. It does not h http://PD0.US/F179494
Phase 3 Study Compares Tapentadol Extended Release Tablets To Placebo In Patients With Chronic Low Back Pain - QualityPoint Technologies
qualitypointtech.net — “Phase 3 safety and efficacy data comparing tapentadol extended release (ER) tablets, an investigational pain medication, to placebo in patients with moderate to severe chronic low back pain have been published online by Expert Opinion on Pharmacotherapy. In addition, this study compared oxycodone controlled-release (CR) to placebo as an active control. Tapentadol ER vs. Placebo The study demonstrated that a significantly higher percentage of patients receiving tapentadol ER tablets achieved at l” View full resource at qualitypointtech.net
Most Recently Shared on September 28, 2010 at 12:00 pm By:
Phase 3 Study Compares Tapentadol Extended Release Tablets To Placebo In Patients With Chronic Low Back Pain: Phas... http://bit.ly/cPcs1D
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
